When.com Web Search

  1. Ads

    related to: pravastatin 10 mg teva 771 dosage

Search results

  1. Results From The WOW.Com Content Network
  2. Pravastatin - Wikipedia

    en.wikipedia.org/wiki/Pravastatin

    Pravastatin has undergone over 112,000 patient-years of double-blind, randomized trials using the 40 mg, once-daily dose and placebos. These trials indicate pravastatin is well tolerated and displays few noncardiovascular abnormalities in patients. [12]

  3. Fenofibrate/pravastatin - Wikipedia

    en.wikipedia.org/wiki/Fenofibrate/pravastatin

    Pravastatin belongs to the group called statins. [2] It reduces total blood cholesterol by blocking the action of 3-hydroxy-3-methyl-glutaryl-coenzyme-A (HMG-CoA) reductase, an enzyme in the liver involved in the production of cholesterol. [ 2 ]

  4. The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice ...

  5. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    The class is on the World Health Organization's List of Essential Medicines with simvastatin being the listed medicine. [10] In 2005, sales were estimated at US$18.7 billion in the United States. [11] The best-selling statin is atorvastatin, also known as Lipitor, which in 2003 became the best-selling pharmaceutical in history. [12]

  6. Teva Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Teva_Pharmaceuticals

    In June 2006, Teva received from the FDA a 180-day exclusivity period to sell simvastatin (Zocor) in the U.S. as a generic drug in all strengths except 80 mg. Teva presently [when?] competes with the maker of brand-name Zocor, Merck & Co.; Ranbaxy Laboratories, which has 180-day exclusivity for the 80 mg strength; and Dr. Reddy's Laboratories ...

  7. PROVE-IT TIMI 22 - Wikipedia

    en.wikipedia.org/wiki/PROVE-IT_TIMI_22

    The Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 trial, also known as PROVE-IT TIMI 22, was a randomized, double-blind, clinical trial that recruited 4,162 people admitted within 10 days of an acute coronary event and randomised them to the lipid-lowering drugs pravastatin (40 mg) or atorvastatin (80 mg) and a 10-day course of the ...